Literature DB >> 7507712

Midodrine for TCA-induced orthostatic hypotension.

D D Maskall, R W Lam.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7507712      PMCID： PMC1188549     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  5 in total

1.  Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine).

Authors:  H Kaufmann; T Brannan; L Krakoff; M D Yahr; J Mandeli
Journal:  Neurology       Date:  1988-06       Impact factor: 9.910

2.  [Treatment of hypotension caused by psychopharmacological drugs (author's transl)].

Authors:  G Hebenstreit
Journal:  Wien Med Wochenschr       Date:  1981-02-28

3.  Midodrine. A new agent in the management of idiopathic orthostatic hypotension and Shy-Drager syndrome.

Authors:  A Schirger; S G Sheps; J E Thomas; R D Fealey
Journal:  Mayo Clin Proc       Date:  1981-07       Impact factor: 7.616

4.  Mineralocorticoid-induced hypertension in patients with orthostatic hypotension.

Authors:  A V Chobanian; L Volicer; C P Tifft; H Gavras; C S Liang; D Faxon
Journal:  N Engl J Med       Date:  1979-07-12       Impact factor: 91.245

Review 5.  Midodrine. A review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders.

Authors:  D McTavish; K L Goa
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546
  5 in total
  1 in total

Review 1.  Antipsychotic pharmacotherapy and orthostatic hypotension: identification and management.

Authors:  James J Gugger
Journal:  CNS Drugs       Date:  2011-08       Impact factor: 5.749
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.